157 related articles for article (PubMed ID: 6345754)
41. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
Lentzen H; Palenker J
FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
[TBL] [Abstract][Full Text] [Related]
42. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
[TBL] [Abstract][Full Text] [Related]
43. [Study of peptide degradation in the serum by 1H-NMR].
Isakova OL; Sepetov NF; Bespalova ZhD; Bushuev VN; Vinogradov VA
Bioorg Khim; 1986 Jan; 12(1):106-11. PubMed ID: 3947404
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of enkephalin by brain enzymes.
Vogel Z; Altstein M
Prog Biochem Pharmacol; 1980; 16():49-59. PubMed ID: 7003599
[TBL] [Abstract][Full Text] [Related]
45. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
Yang JZ; Chen W; Borchardt RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
[TBL] [Abstract][Full Text] [Related]
46. The behaviour of different markers of the mucosal extracellular space in rat small intestine.
Böhmer R; Rommel K
Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):398-403. PubMed ID: 1211066
[TBL] [Abstract][Full Text] [Related]
47. [Substrates for enkephalin-forming carboxypeptidase in the rat brain and adrenals].
Rostovtsev AP; Grigor'iants OO; Gomazkov OA
Vopr Med Khim; 1988; 34(1):126-9. PubMed ID: 3130720
[TBL] [Abstract][Full Text] [Related]
48. 2-substituted-N5-(2'-aminophenyl)-4-thiohydantoic acids as aminopeptidase inhibitors with pro-antinociceptive activity.
Yu Z; Williams PS; Patel A; Smith HJ; Sewell RD; Gonzalez JP
Prog Clin Biol Res; 1990; 328():481-4. PubMed ID: 2406761
[No Abstract] [Full Text] [Related]
49. Dual system of intestinal thiamine transport in humans.
Hoyumpa AM; Strickland R; Sheehan JJ; Yarborough G; Nichols S
J Lab Clin Med; 1982 May; 99(5):701-8. PubMed ID: 6279749
[TBL] [Abstract][Full Text] [Related]
50. Evidence for a single common carrier for uptake of a dipeptide and a tripeptide by hamster jejunum in vitro.
Sleisenger MH; Burston D; Dalrymple JA; Wilkinson S; Mathews DM
Gastroenterology; 1976 Jul; 71(1):76-81. PubMed ID: 1278652
[TBL] [Abstract][Full Text] [Related]
51. Factors that restrict intestinal cell permeation of cyclic prodrugs of an opioid peptide (DADLE): Part II. Role of metabolic enzymes in the intestinal mucosa.
Ouyang H; Chen W; Andersen TE; Steffansen B; Borchardt RT
J Pharm Sci; 2009 Jan; 98(1):349-61. PubMed ID: 18537150
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H]leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Sep; 79(9):768-70. PubMed ID: 2273455
[TBL] [Abstract][Full Text] [Related]
53. [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human plasma].
Zolotarev IuA; Sokolov OIu; Kost NV; Vas'kovskiĭ BV; Miasoedov NF; Zozulia AA
Bioorg Khim; 2004; 30(3):234-40. PubMed ID: 15344652
[TBL] [Abstract][Full Text] [Related]
54. Plasma uptake and in vivo metabolism of [Leu]enkephalin following its intraperitoneal administration to rats.
Schulteis G; Weinberger SB; Martinez JL
Peptides; 1989; 10(5):913-9. PubMed ID: 2691996
[TBL] [Abstract][Full Text] [Related]
55. Evidence for two different broad-specificity oligopeptide transporters in intestinal cell line Caco-2 and colonic cell line CCD841.
Chothe P; Singh N; Ganapathy V
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1260-9. PubMed ID: 21307350
[TBL] [Abstract][Full Text] [Related]
56. The metabolism of neuropeptides. Both phosphoramidon-sensitive and captopril-sensitive metallopeptidases are present in the electric organ of Torpedo marmorata.
Turner AJ; Dowdall MJ
Biochem J; 1984 Aug; 222(1):255-9. PubMed ID: 6383356
[TBL] [Abstract][Full Text] [Related]
57. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
[TBL] [Abstract][Full Text] [Related]
58. Hepatic inactivation of Leu-enkephalin.
MacKinnon KL; Zuzel KA; Billington D
Regul Pept; 1996 Dec; 67(2):85-92. PubMed ID: 8958578
[TBL] [Abstract][Full Text] [Related]
59. An in vitro evaluation of metabolism and poor membrane permeation impeding intestinal absorption of leucine enkephalin, and methods to increase absorption.
Aungst BJ; Blake JA; Hussain MA
J Pharmacol Exp Ther; 1991 Oct; 259(1):139-45. PubMed ID: 1920113
[TBL] [Abstract][Full Text] [Related]
60. Proabsorptive properties of forskolin: disposition of glycine, leucine and lysine in rat jejunum.
Reymann A; Braun W; Woermann C
Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):110-5. PubMed ID: 3024021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
